{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:08:48Z","timestamp":1791094128382,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3035,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.ijid.2004.09.009","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T14:28:51Z","timestamp":1112624931000},"page":"127-138","source":"Crossref","is-referenced-by-count":233,"title":["Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?"],"prefix":"10.1016","volume":"9","author":[{"given":"Luca","family":"Lazzarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2004.09.009_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(00)41962-8","article-title":"General and local administration of penicillin","volume":"1","author":"Florey","year":"1943","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2004.09.009_bib2","series-title":"Source Book of Orthopaedics","author":"Bick","year":"1968"},{"key":"10.1016\/j.ijid.2004.09.009_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11908-002-0012-4","article-title":"Long bone osteomyelitis","volume":"4","author":"Lazzarini","year":"2002","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijid.2004.09.009_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0891-5520(20)30352-4","article-title":"Animal models of osteomyelitis: knowledge, hypothesis and speculation","volume":"4","author":"Rissing","year":"1990","journal-title":"Infect Dis Clin North Am"},{"issue":"suppl 3","key":"10.1016\/j.ijid.2004.09.009_bib5","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1093\/clinids\/5.Supplement_3.S495","article-title":"Chronic staphylococcal osteomyelitis: treatment with regimens containing rifampin","volume":"5","author":"Norden","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00007611-198608000-00008","article-title":"Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy","volume":"79","author":"Norden","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.ijid.2004.09.009_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jac\/43.1.113","article-title":"The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis","volume":"43","author":"Leder","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(68)90520-5","article-title":"Oral penicillins in the treatment of chronic staphylococcal osteomyelitis","volume":"10","author":"Bell","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2004.09.009_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00007611-197507000-00006","article-title":"Antibiotics in the treatment of chronic staphylococcal osteomyelitis","volume":"68","author":"Hodgkin","year":"1975","journal-title":"South Med J"},{"key":"10.1016\/j.ijid.2004.09.009_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3476(79)80049-9","article-title":"High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children","volume":"94","author":"Bryson","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijid.2004.09.009_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1302\/0301-620X.64B2.6802854","article-title":"Treatment of acute osteomyelitis in childhood","volume":"64B","author":"Cole","year":"1982","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.ijid.2004.09.009_bib12","first-page":"480","article-title":"A controlled trial of cloxacillin and tetracycline in chronic staphylococcal osteomyelitis in Ugandan children","volume":"50","author":"Hubbard","year":"1973","journal-title":"East Afr Med J"},{"key":"10.1016\/j.ijid.2004.09.009_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/inf.1975.7.issue-1.10","article-title":"Treatment of chronic staphylococcal osteomyelitis with cloxacillin and dicloxacillin \u2013 a comparative study in 12 patients","volume":"5","author":"Hedstrom","year":"1975","journal-title":"Scand J Infect Dis"},{"issue":"suppl 5B","key":"10.1016\/j.ijid.2004.09.009_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-9343(85)90142-1","article-title":"Ticarcillin plus clavulanic acid therapy for osteomyelitis","volume":"79","author":"Gentry","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 5B","key":"10.1016\/j.ijid.2004.09.009_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9343(85)90158-5","article-title":"Timentin therapy for bone, joint, and deep soft tissue infection in children","volume":"79","author":"Jacobs","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 5B","key":"10.1016\/j.ijid.2004.09.009_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9343(85)90148-2","article-title":"Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections","volume":"79","author":"Siebert","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 5B","key":"10.1016\/j.ijid.2004.09.009_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0002-9343(85)90147-0","article-title":"Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint","volume":"79","author":"Johnson","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 5","key":"10.1016\/j.ijid.2004.09.009_bib18","doi-asserted-by":"crossref","first-page":"S569","DOI":"10.1093\/clinids\/8.Supplement_5.S569","article-title":"A randomized, double blinded comparison of sulbactam\/ampicillin and clindamycin for the treatment of aerobic and aerobic\/anaerobic infections","volume":"8","author":"Reinhardt","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"suppl 5","key":"10.1016\/j.ijid.2004.09.009_bib19","first-page":"S569","article-title":"An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections","volume":"8","author":"Loffler","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00006454-198909000-00008","article-title":"Randomized comparative study of ampicillin\/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children","volume":"8","author":"Kulhanjian","year":"1989","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib21","first-page":"489","article-title":"Traitement des infections osseuses et articulaires de l\u2019enfant par la pristinamycine","volume":"38","author":"Beauvais","year":"1981","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.ijid.2004.09.009_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1542\/peds.55.2.213","article-title":"Clindamycin treatment of osteomyelitis and septic arthritis in children","volume":"55","author":"Feigin","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2004.09.009_bib23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpedi.1977.02120230034005","article-title":"Clindamycin in the treatment of osteomyelitis in children","volume":"131","author":"Rodriguez","year":"1977","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ijid.2004.09.009_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00007611-198202000-00005","article-title":"Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children","volume":"75","author":"Kaplan","year":"1982","journal-title":"South Med J"},{"key":"10.1016\/j.ijid.2004.09.009_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.26.2.245","article-title":"Evaluation of aztreonam in difficult-to-treat infections with prolonged posttreatment follow-up","volume":"26","author":"Giamarellou","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/150.5.623","article-title":"Treatment of serious gram-negative infections with aztreonam","volume":"150","author":"Greenberg","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0002-9343(85)90435-8","article-title":"Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa","volume":"78","author":"Scully","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 2A","key":"10.1016\/j.ijid.2004.09.009_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9343(85)90205-0","article-title":"Aztreonam in the treatment of serious orthopedic infections","volume":"78","author":"Prybil","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 4","key":"10.1016\/j.ijid.2004.09.009_bib29","doi-asserted-by":"crossref","first-page":"S783","DOI":"10.1093\/clinids\/7.Supplement_4.S783","article-title":"Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli","volume":"7","author":"Simons","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"suppl 7","key":"10.1016\/j.ijid.2004.09.009_bib30","doi-asserted-by":"crossref","first-page":"S634","DOI":"10.1093\/clinids\/13.Supplement_7.S634","article-title":"Efficacy of aztreonam in the treatment of skeletal infections due to Pseudomonas aeruginosa","volume":"13","author":"Conrad","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/030006058301100504","article-title":"Moxalactam therapy of difficult infections in patients with serious underlying conditions","volume":"11","author":"Mogabgab","year":"1983","journal-title":"J Int Med Res"},{"issue":"suppl 6A","key":"10.1016\/j.ijid.2004.09.009_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-9343(85)90109-3","article-title":"Imipenem\/Cilastatin in the treatment of osteomyelitis","volume":"78","author":"MacGregor","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2004.09.009_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1469-0691.1997.tb00280.x","article-title":"Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic gram-positive bone and joint infections","volume":"3","author":"Bernard","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2004.09.009_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/23.1.131","article-title":"Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria","volume":"23","author":"de Lalla","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jac\/25.3.435","article-title":"Treatment of bone and soft tissue infections with teicoplanin","volume":"25","author":"Marone","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib36","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1128\/AAC.34.12.2392","article-title":"Treatment of bone, joint and vascular-access-associated Gram-positive bacterial infections with teicoplain","volume":"34","author":"Greenberg","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00007611-199308000-00009","article-title":"Safety and efficacy of teicoplanin for bone and joint infections: result of a community-based trial","volume":"86","author":"Weinberg","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/j.ijid.2004.09.009_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-199700546-00006","article-title":"Management of serious staphylococcal infections in the outpatient setting","volume":"54","author":"Graninger","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ijid.2004.09.009_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s101560050005","article-title":"Teicoplanin in the treatment of bone and joint infections: an open study","volume":"5","author":"LeFrock","year":"1999","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1179\/joc.2000.12.5.412","article-title":"Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients","volume":"12","author":"Testore","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib41","first-page":"186","article-title":"Co-trimoxazole in the treatment of chronic osteomyelitis","volume":"71","author":"Saengnipanthkul","year":"1988","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ijid.2004.09.009_bib42","first-page":"10","article-title":"Cotrimoxazol mas rifampicina en el tratamiento de la infeccion osteoarticular estafilococica","volume":"15","author":"Sanchez","year":"1997","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijid.2004.09.009_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000221921","article-title":"Fosfomycin in osteomyelitis","volume":"22","author":"Fernandez-Valencia","year":"1976","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijid.2004.09.009_bib44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1302\/0301-620X.56B4.721","article-title":"Antibiotic therapy of chronic post-traumatic osteomyelitis","volume":"56B","author":"Hierolzer","year":"1974","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.ijid.2004.09.009_bib45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1185\/03007998509109638","article-title":"Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci","volume":"9","author":"Coombs","year":"1985","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijid.2004.09.009_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/030006057600400307","article-title":"Effectiveness of two new cephalosporins, cephazolin and cephapirin, administered intermittently in acute and chronic osteomyelitis in children","volume":"4","author":"Arango","year":"1976","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijid.2004.09.009_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.13.3.405","article-title":"Treatment of osteomyelitis and septic arthritis with cefazolin","volume":"13","author":"Fass","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/4.suppl_B.235","article-title":"Osteomyelitis treated with cefoxitin sodium","volume":"4","author":"Liu","year":"1978","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/clinids\/1.1.206","article-title":"Clinical evaluation of cefoxitin in the treatment of infections in 47 orthopedic patients","volume":"1","author":"Schurman","year":"1979","journal-title":"Rev Infect Dis"},{"issue":"suppl","key":"10.1016\/j.ijid.2004.09.009_bib50","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/infdis\/137.Supplement.S119","article-title":"Clinical experience with cefamandole for treatment of serious bone and joint infections","volume":"137","author":"Levine","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00000441-198211000-00001","article-title":"Treatment of osteomyelitis and septic arthritis with cefamandole","volume":"284","author":"Bernstein","year":"1982","journal-title":"Am J Med Sc"},{"issue":"suppl","key":"10.1016\/j.ijid.2004.09.009_bib52","first-page":"89","article-title":"Cefamandole in the treatment of serious bone and joint diseases","volume":"25","author":"Levine","year":"1980","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib53","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/106002808101501206","article-title":"Use of cefamandole in the treatment of soft tissue and skeletal infections","volume":"15","author":"LeFrock","year":"1981","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.ijid.2004.09.009_bib54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01241398-198208000-00004","article-title":"Benefits and risks of sequential parenteral-oral cephalosporins therapy for suppurative bone and joint infections","volume":"2","author":"Nelson","year":"1982","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.ijid.2004.09.009_bib55","first-page":"450","article-title":"Cefoperazone therapy for serious infections","volume":"4","author":"Temple","year":"1982","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijid.2004.09.009_bib56","first-page":"18","article-title":"Cefoperazone in the treatment of osteomyelitis","volume":"6","author":"Biehl","year":"1983","journal-title":"Clin Ther"},{"issue":"suppl","key":"10.1016\/j.ijid.2004.09.009_bib57","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1093\/clinids\/4.Supplement_2.S465","article-title":"Clinical experience with cefotaxime in the treatment of serious bone and joint infections","volume":"4","author":"LeFrock","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"suppl","key":"10.1016\/j.ijid.2004.09.009_bib58","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1093\/clinids\/4.Supplement_2.S472","article-title":"Cefotaxime therapy for patients with osteomyelitis and septic arthritis","volume":"4","author":"Mader","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"suppl A","key":"10.1016\/j.ijid.2004.09.009_bib59","first-page":"10","article-title":"Cefotaxime treatment in patients with osteomyelitis and septic arthritis: a multicenter study","volume":"5","author":"Mader","year":"1982","journal-title":"Clin Ther"},{"issue":"suppl 1","key":"10.1016\/j.ijid.2004.09.009_bib60","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/BF01644219","article-title":"Bone and Joint infections caused by gram positive bacteria: treatment with cefotaxime","volume":"13","author":"LeFrock","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2004.09.009_bib61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/14.1.56","article-title":"Safety profile and efficacy of cefotaxime for the treatment of hospitalized children","volume":"14","author":"Jacobs","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"suppl C","key":"10.1016\/j.ijid.2004.09.009_bib62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/10.suppl_C.265","article-title":"Treatment of acute and chronic osteomyelitis with ceftizoxime","volume":"10","author":"Mader","year":"1982","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1016\/j.ijid.2004.09.009_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/26.suppl_A.45","article-title":"Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli","volume":"26","author":"Gomis","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1016\/j.ijid.2004.09.009_bib64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/12.suppl_A.229","article-title":"The treatment of bone infections with ceftazidime","volume":"12","author":"Dutoy","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1016\/j.ijid.2004.09.009_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/12.suppl_A.161","article-title":"Ceftazidime in patients with pseudomonas infections","volume":"12","author":"Eron","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib66","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/AAC.31.10.1605","article-title":"Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis","volume":"31","author":"Bach","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib67","first-page":"677","article-title":"Use of ceftazidime in the treatment of osteomyelitis and osteoarthritis","volume":"12","author":"De Bastiani","year":"1986","journal-title":"Int J Clin Pharm Ther Toxicol"},{"key":"10.1016\/j.ijid.2004.09.009_bib68","first-page":"321","article-title":"Ceftriaxone: therapeutic results in various infections and kinetic studies","volume":"34","author":"Giamarellou","year":"1984","journal-title":"Drug Res"},{"key":"10.1016\/j.ijid.2004.09.009_bib69","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00006454-198605000-00005","article-title":"Once daily ceftriaxone for central nervous system infections and other serious pediatric infections","volume":"5","author":"Yogev","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"suppl 3","key":"10.1016\/j.ijid.2004.09.009_bib70","doi-asserted-by":"crossref","first-page":"S728","DOI":"10.1093\/clinids\/6.Supplement_3.S728","article-title":"Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa","volume":"6","author":"Pottage","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/030006058601400504","article-title":"Cefsulodin treatment for serious Pseudomonas aeruginosa infections","volume":"14","author":"Routman","year":"1986","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijid.2004.09.009_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01739916","article-title":"Prolonged treatment of chronic Pseudomonas aeruginosa osteomyelitis with a combination of two effective antibiotics","volume":"22","author":"Lucht","year":"1994","journal-title":"Infection"},{"issue":"suppl 6A","key":"10.1016\/j.ijid.2004.09.009_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9343(84)80068-6","article-title":"Cefmenoxime therapy in bacterial osteomyelitis","volume":"77","author":"Sheftel","year":"1984","journal-title":"Am J Med"},{"issue":"suppl B","key":"10.1016\/j.ijid.2004.09.009_bib74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/32.suppl_B.141","article-title":"Cefepime as treatment for osteomyelitis and other severe bacterial infections","volume":"32","author":"Jauregui","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 4","key":"10.1016\/j.ijid.2004.09.009_bib75","doi-asserted-by":"crossref","first-page":"S865","DOI":"10.1093\/clinids\/6.Supplement_4.S865","article-title":"Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting","volume":"6","author":"Kunkel","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.28.1.128","article-title":"Open, prospective study of the clinical efficacy of ciprofloxacin","volume":"28","author":"Ramirez","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib77","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(86)90937-2","article-title":"Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa","volume":"1","author":"Scully","year":"1986","journal-title":"Lancet"},{"issue":"suppl 4A","key":"10.1016\/j.ijid.2004.09.009_bib78","first-page":"259","article-title":"Oral ciprofloxacin therapy for osteomyelitis caused by aerobic gram negative bacilli","volume":"82","author":"Slama","year":"1987","journal-title":"Am J Med"},{"issue":"suppl 4A","key":"10.1016\/j.ijid.2004.09.009_bib79","first-page":"254","article-title":"Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli","volume":"82","author":"Gilbert","year":"1987","journal-title":"Am J Med"},{"issue":"suppl 4A","key":"10.1016\/j.ijid.2004.09.009_bib80","first-page":"262","article-title":"Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis","volume":"82","author":"Trexler Hessen","year":"1987","journal-title":"Am J Med"},{"issue":"suppl 5A","key":"10.1016\/j.ijid.2004.09.009_bib81","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/0002-9343(89)90063-6","article-title":"Intravenous ciprofloxacin therapy in severe infections","volume":"87","author":"Gudiol","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2004.09.009_bib82","first-page":"47","article-title":"Evaluacion de la ciprofloxacina en el tratamiento de infecciones bacterianas graves","volume":"7","author":"Lopez","year":"1989","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijid.2004.09.009_bib83","first-page":"75","article-title":"Oral ciprofloxacin for treatment of chronic osteomyelitis","volume":"12","author":"Yamaguti","year":"1993","journal-title":"Int J Clin Pharm Res"},{"key":"10.1016\/j.ijid.2004.09.009_bib84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.34.5.849","article-title":"Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis","volume":"34","author":"Dan","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3928\/0147-7447-19900101-10","article-title":"Oral ciprofloxacin for osteomyelitis","volume":"13","author":"MacGregor","year":"1990","journal-title":"Orthopedics"},{"issue":"suppl C","key":"10.1016\/j.ijid.2004.09.009_bib86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/22.Supplement_C.159","article-title":"Use of ofloxacin in open fractures and in the treatment of post-traumatic osteomyelitis","volume":"22","author":"Ketterl","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib87","first-page":"64","article-title":"Clinical experience with parenteral and oral ofloxacin in severe infections","volume":"68","author":"Kannellakopoulou","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0732-8893(92)90085-8","article-title":"Oral ofloxacin for infection caused by bacteria resistant to oral antimicrobial agents","volume":"15","author":"Eron","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib89","first-page":"514","article-title":"Clinical evaluation of fleroxacin in the treatment of bone and joint infections","volume":"23","author":"Liu","year":"1992","journal-title":"Southeast Asian J Trop Med Pub Health"},{"key":"10.1016\/j.ijid.2004.09.009_bib90","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF01975163","article-title":"Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis","volume":"8","author":"Dellamonica","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.44.1.164-166.2000","article-title":"Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis","volume":"44","author":"Greenberg","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib92","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/AAC.33.8.1362","article-title":"Pefloxacin versus ceftazidime in the treatment of a variety of gram negative bacterial infections","volume":"33","author":"Giamarellou","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib93","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/AAC.35.3.538","article-title":"Ofloxacin versus parenteral therapy for chronic osteomyelitis","volume":"35","author":"Gentry","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib94","first-page":"244","article-title":"Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis","volume":"12","author":"Gomis","year":"1999","journal-title":"Rev Esp Quimioterap"},{"key":"10.1016\/j.ijid.2004.09.009_bib95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.34.1.40","article-title":"Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis","volume":"34","author":"Gentry","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2106\/00004623-199072010-00017","article-title":"Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults","volume":"72A","author":"Mader","year":"1990","journal-title":"J Bone Joint Surg Am"},{"issue":"suppl 4A","key":"10.1016\/j.ijid.2004.09.009_bib97","first-page":"266","article-title":"Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis","volume":"82","author":"Greenberg","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2004.09.009_bib98","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.ijid.2004.09.009_bib99","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/clind\/15.Supplement_1.S155","article-title":"Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults","volume":"15","author":"Mader","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/516149","article-title":"Staging and staging application in osteomyelitis","volume":"25","author":"Mader","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib101","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1302\/0301-620X.83B3.10727","article-title":"Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival","volume":"83","author":"Simpson","year":"2001","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.ijid.2004.09.009_bib102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/clinids\/10.1.103","article-title":"Lessons learned from animal models of osteomyelitis","volume":"10","author":"Norden","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2004.09.009_bib103","series-title":"Infectious Diseases","first-page":"1339","article-title":"Osteomyelitis","author":"Waldvogel","year":"1988"},{"key":"10.1016\/j.ijid.2004.09.009_bib104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(88)91013-6","article-title":"Duration of antimicrobial therapy for acute suppurative osteoarticular infections","volume":"1","author":"Syrogiannopoulos","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2004.09.009_bib105","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dkg186","article-title":"Risk factors and treatment outcomes in osteomyelitis","volume":"51","author":"Tice","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/dkf066","article-title":"Penetration of linezolid into bone, fat, muscle and haematoma of patients underoing routine hip replacement","volume":"50","author":"Lovering","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2004.09.009_bib107","unstructured":"Rao N, Ziran BH, Santa ER. Treatment of chronic osteomyelitis with linezolid. Abstract 195, Program and Abstracts of the 40th Annual Meeting of IDSA, October 24\u201327, 2002. Chicago, IL."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971205000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971205000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T16:02:08Z","timestamp":1706112128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971205000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1201971205000123"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2004.09.009","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}